|
Resolution: standard / high Figure 3.
Identification of Bcl-GL as an interacting protein for MELK. (a) Silver staining of SDS-PAGE gels that contained the pulled-down cell lysates. The
enlarged area covering Bcl-G shows the differential interaction between it and wild-type
MELK (WT-MELK) and kinase-dead MELK (D150A-MELK). (b) Expression of Bcl-GL in eight breast cancer cell lines as well as human mammary epithelial cells (HMECs)
by western blot analysis with an anti-Bcl-GL antibody. β-Actin was used as a control. (c) Interaction of MELK with Bcl-GL. Extracts from HeLa-cells transfected with HA (hemagglutinin)-tagged WT-MELK (HA-WT-MELK)
or Flag-tagged Bcl-GL (Flag-Bcl-GL), or a combination of these, were harvested 36 hours after transfection. The cell
lysates were immunoprecipitated with anti-Flag M2 antibody. Precipitated proteins
were separated by SDS-PAGE and western blotting analysis was performed with an anti-HA
antibody. (d) Direct interaction of the MELK and Bcl-GL proteins. The upper panel indicates the amount of input of WT-MELK and D150A-MELK.
His-tagged WT-MELK bound to Bcl-GL, but His-tagged D150A-MELK did not. (e) Schematic representation of the amino- and carboxy-terminal deletion constructs of
Bcl-GL. The C-1 and C-2 constructs have the BH2 domain deleted, and the C-3 construct has
both the BH2 and BH3 domains deleted. (f) Determination of the WT-MELK binding regions of Bcl-GL by immunoprecipitation. The HA-tagged WT-MELK and various peptide sequences of Flag-tagged
Bcl-GL (Figure 3e) were pulled down by immunoprecipitation with Flag-M2 antibody and then
immunoblotted with rabbit anti-Flag antibody. The expression of HA-tagged WT-MELK
in total cell lysates was confirmed by western blotting analysis. As a control, immunoprecipitation
was performed from cells co-transfected with pCAGGSn3FC (Mock) and HA-tagged WT-MELK
(HA-WT-MELK) through all steps. Arrowheads indicate expression of each Bcl-GL peptide.
Lin et al. Breast Cancer Research 2007 9:R17 doi:10.1186/bcr1650 |